Ravimtablett

Ravimtablett is a term used to describe a solid dosage form intended for oral administration that contains an active pharmaceutical ingredient (API) mixed with excipients to aid manufacturing, stability, and delivery. Tablets are typically produced by compressing a blend of powders and can be uncoated or coated to improve taste, protect the API, or control release. Common variants include standard tablets, chewable tablets, sublingual tablets, orally disintegrating tablets, and effervescent tablets.

Composition and forms

A ravimtablett combines an API with excipients such as fillers, binders, disintegrants, lubricants, and sometimes sweeteners or flavorings. Binders help hold the tablet together; fillers provide bulk; disintegrants promote breakup in the gastrointestinal tract; lubricants reduce friction during manufacture. Coatings may be applied to mask taste, shield the drug from moisture or light, or modify the release profile. The release mechanism can be immediate, extended, or delayed, depending on therapeutic needs.

Manufacturing

Tablet production typically involves formulation development, granulation (wet or dry), blending, compression into tablets, and optional coating. Quality control ensures uniform content, appropriate hardness, disintegration time, and dissolution behavior, along with stability under storage conditions.

Quality and regulation

Ravimtabletts are subject to regulatory oversight to ensure safety, efficacy, and quality. Specifications address content uniformity, friability, disintegration, dissolution, and shelf life. Labeling provides dosage, administration instructions, contraindications, and storage guidance, with patient information tailored to regulatory requirements in different regions.

Safety and storage

Tablets can cause adverse effects or interact with other medicines. Some tablets must not be chewed or crushed, depending on their design. Storage typically requires a cool, dry place away from direct sunlight.